Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Misoprostol Prior to Office Hysteroscopy
NCT01612065Phase 3Completed
- Sponsor
- Cairo University
- Start
- Jun 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of misoprostol in infertility, abnormal uterine bleeding (AUB) and recurrent pregnancy loss (RPL) (2 arms), sponsored by Cairo University. Primary endpoint: Pain score at 1 year. Started Jun 2012; status: completed.
02
Drugs
misoprostol
03
Conditions
infertilityabnormal uterine bleeding (AUB)recurrent pregnancy loss (RPL)
Beyond the preview
Go deeper on NCT01612065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01612065.